183
Participants
Start Date
September 30, 2013
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
Ranibizumab
Ranibizumab 0.5mg/0.5mL was administered intravitreally to the participant.
Sham control
The sham vial did not contain active drug (empty sterile vial). The sham injection was an imitation of an intravitreal injection using an injection syringe without a needle touching the eye.
Novartis Investigative Site, San Isidro
Novartis Investigative Site, Riga
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Sydney
Novartis Investigative Site, Glostrup Municipality
Novartis Investigative Site, Bern
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Binningen
Novartis Investigative Site, Adelaide
Novartis Investigative Site, South Launceston
Novartis Investigative Site, Milan
Novartis Investigative Site, Varese
Novartis Investigative Site, Málaga
Novartis Investigative Site, Udine
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Kocaeli
Novartis Investigative Site, Bochum
Novartis Investigative Site, Valladolid
Novartis Investigative Site, Münster
Novartis Investigative Site, Münster
Novartis Investigative Site, Kaunas
Novartis Investigative Site, Bonn
Novartis Investigative Site, Bari
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Paris
Novartis Investigative Site, Freiburg I. Br
Novartis Investigative Site, Trenčín
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Catania
Novartis Investigative Site, Banská Bystrica
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Singapore
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Montreal
Novartis Investigative Site, Hradec Králové
Novartis Investigative Site, Prague
Novartis Investigative Site, Paris
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Pátrai
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Heraklion Crete
Novartis Investigative Site, Szeged
Novartis Investigative Site, Roma
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Katowice
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Porto
Novartis Investigative Site, Busan
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Sant Cugat del Vallès
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY